OptimizeRx Corp. (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility is structured as a $25 million term loan and a $10 million revolving credit facility, which was undrawn at the time of closing. Roth Capital Partners served as financial advisor on the transaction.
The credit facility provides OptimizeRx with additional financial flexibility to execute its strategic growth initiatives. The company's platform combines artificial intelligence-driven tools, including the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT), to deliver hyper-local engagement between life science brands and healthcare providers and patients. By bridging the gap between healthcare provider and direct-to-consumer strategies, OptimizeRx aims to drive faster treatment decisions and improve patient outcomes.
This financing comes at a time when the healthcare technology sector is increasingly focused on patient-centric, privacy-safe solutions. OptimizeRx's commitment to these principles positions it to partner with leading pharmaceutical and life sciences companies to transform the healthcare landscape. The new credit facility will likely enable the company to invest further in its technology platform and expand its market reach.
For more details on the announcement, visit https://ibn.fm/G0Fj3. Additional information about OptimizeRx is available at www.optimizerx.com.
